US politics
fromwww.mercurynews.com
4 days agoJarvis: The FDA's mifepristone decision has baffled both sides
FDA approval of a second generic mifepristone has intensified debate and prompted pressure on federal authorities while antiabortion groups escalate campaigns and misinformation.